Advanced Science, Volume 13, Issue 20, 9 April 2026.Nanozymes, as enzyme‐mimicking nanomaterials, exhibit unique catalytic properties for the treatment of liver diseases. By regulating redox homeostasis, modulating immune responses, and enabling targeted delivery, nanozymes overcome the limitations of natural enzymes.
Xiandi Meng +6 more
wiley +1 more source
Exosomes for Polycystic Ovary Syndrome Treatment: Mechanisms and Therapeutic Potential. [PDF]
Int J NanomedicineLiu P, Sha Y, Yang H, Liu T.
europepmc +1 more source
Gendering the Menstrual Cycle in Behavioral Neuroendocrinology
American Journal of Human Biology, Volume 38, Issue 4, April 2026.ABSTRACT The menstrual cycle is increasingly described as a “vital sign of the female body,” with the literature suggesting cycle‐related brain and behavioral changes. With growing interest in the effects that the menstrual cycle has on the brain, body and mind, characterizing what constitutes healthy cycle‐related change has become a central goal of ...
Annie Duchesne +2 more
wiley +1 more source
Identification of Compound Heterozygous CYP11A1 Variants via Reanalysis of Clinical Sequencing Data
American Journal of Medical Genetics Part A, Volume 200, Issue 4, Page 923-928, April 2026.ABSTRACT A molecular diagnosis is currently achievable in approximately 50% of patients assessed by clinical geneticists at tertiary care centres. Next‐Generation Sequencing Panels contain a defined group of genes associated with a clinically defined set of phenotypes.
Ana Acosta Bedón +10 more
wiley +1 more source
AMH specifically targets neuronal AMHR2 to modulate the progression of polycystic ovary syndrome. [PDF]
BMC Endocr DisordWu K +8 more
europepmc +1 more source
Longitudinal Behavior Phenotype Hallmarks in RNU4‐2 Syndrome: Implications for Clinical Management
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, Volume 201, Issue 3, Page 205-211, April 2026.ABSTRACT Pathogenic variants in the non‐coding spliceosomal gene RNU4‐2 underlie ReNU syndrome, one of the most prevalent monogenic causes of neurodevelopmental disorders, accounting for ~0.4% of cases. Despite increasing recognition, little is known about the longitudinal behavioral and neuropsychiatric phenotype of affected individuals. We report two
Paola Francesca Ajmone +8 more
wiley +1 more source
Natural Products in the Metabolic and Endocrine Modulation of Polycystic Ovary Syndrome: Current Perspectives. [PDF]
NutrientsLiu S +6 more
europepmc +1 more source
Bacterial Infections Role in Gynecological Cancers Development: Narrative Review
Cancer Reports, Volume 9, Issue 4, April 2026.ABSTRACT Background Gynecological cancers are among the most common cancers in women that affect female reproductive organs. The most common gynecological cancers are ovarian, cervical, uterine/endometrial, vaginal, and vulvar cancer. Women's reproductive organs have a dynamic and relative microbial balance.
Robab Azargun +7 more
wiley +1 more source
Comparative analysis of hormonal and metabolic indices in phenotypic subgroups of polycystic ovary syndrome. [PDF]
J Turk Ger Gynecol AssocSavran Üçok B +6 more
europepmc +1 more source
Comprehensive Physiology, Volume 16, Issue 2, April 2026.Extracellular vesicles (EVs) mediate intercellular and interorgan communication during both physiological and pathological conditions. EVs include exosomes, ectosomes, and apoptotic bodies and contain bioactive molecules. EVs are delivered to proximal cells or can travel in bodily fluids and reach distant organs, where they trigger a response from the ...
Michela Saviana +4 more
wiley +1 more source